trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Inflammation D007249 119 associated lipids
Hypertension D006973 115 associated lipids
Glioma D005910 112 associated lipids
Atherosclerosis D050197 85 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Alzheimer Disease D000544 76 associated lipids
Leukemia D007938 74 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Melanoma D008545 69 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Neuroblastoma D009447 66 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Reperfusion Injury D015427 65 associated lipids
Nerve Degeneration D009410 53 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Asthma D001249 52 associated lipids
Osteosarcoma D012516 50 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Stroke D020521 32 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Cardiomegaly D006332 31 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Endometriosis D004715 29 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Glioblastoma D005909 27 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Nasal Polyps D009298 26 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Breast Neoplasms D001943 24 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Amin HM et al. Histone deacetylase inhibitors induce caspase-dependent apoptosis and downregulation of daxx in acute promyelocytic leukaemia with t(15;17). 2001 Br. J. Haematol. pmid:11703323
Jacob AL et al. Acetylation of steroidogenic factor 1 protein regulates its transcriptional activity and recruits the coactivator GCN5. 2001 J. Biol. Chem. pmid:11479297
Sourlingas TG et al. Histone deacetylase inhibitors induce apoptosis in peripheral blood lymphocytes along with histone H4 acetylation and the expression of the linker histone variant, H1 degrees. 2001 Eur. J. Cell Biol. pmid:11824792
Li J et al. Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphorylation-acetylation. 2001 Mol. Cell. Biol. pmid:11689710
Hirschler-Laszkiewicz I et al. The role of acetylation in rDNA transcription. 2001 Nucleic Acids Res. pmid:11600700
Nair AR et al. Paradoxical effects of trichostatin A: inhibition of NF-Y-associated histone acetyltransferase activity, phosphorylation of hGCN5 and downregulation of cyclin A and B1 mRNA. 2001 Cancer Lett. pmid:11295287
Hatama S et al. Reactivation of feline foamy virus from a chronically infected feline renal cell line by trichostatin A. 2001 Virology pmid:11336556
Viollet B et al. Embryonic but not postnatal reexpression of hepatocyte nuclear factor 1alpha (HNF1alpha) can reactivate the silent phenylalanine hydroxylase gene in HNF1alpha-deficient hepatocytes. 2001 Mol. Cell. Biol. pmid:11340160
Nakamura M et al. Reduction of telomerase activity in human liver cancer cells by a histone deacetylase inhibitor. 2001 J. Cell. Physiol. pmid:11319763
Xu D et al. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. 2001 Proc. Natl. Acad. Sci. U.S.A. pmid:11274400
Seth KA and Majzoub JA Repressor element silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) can act as an enhancer as well as a repressor of corticotropin-releasing hormone gene transcription. 2001 J. Biol. Chem. pmid:11278361
Singal R et al. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells. 2001 Cancer Res. pmid:11406558
Baur JA et al. Telomere position effect in human cells. 2001 Science pmid:11408657
Zelivianski S et al. Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype. 2001 Biochim. Biophys. Acta pmid:11389966
Harada Y et al. A hematopoietic-specific transmembrane protein, Art-1, is possibly regulated by AML1. 2001 Biochem. Biophys. Res. Commun. pmid:11396961
Osborne A et al. Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation. 2001 Mol. Cell. Biol. pmid:11533238
Yang H et al. Role of promoter methylation in increased methionine adenosyltransferase 2A expression in human liver cancer. 2001 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:11208539
Chen C et al. Evidence that silencing of the HPRT promoter by DNA methylation is mediated by critical CpG sites. 2001 J. Biol. Chem. pmid:11013250
Ullerås E et al. Inhibition of histone deacetylase activity causes cell type-specific induction of the PDGF-B promoter only in the absence of activation by its enhancer. 2001 Exp. Cell Res. pmid:11640883
Wu JT et al. Transient vs. prolonged histone hyperacetylation: effects on colon cancer cell growth, differentiation, and apoptosis. 2001 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:11171632
Taddei A et al. Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases. 2001 Nat. Cell Biol. pmid:11175742
Biade S et al. Chemical agents that promote chromatin compaction radiosensitize tumour cells. 2001 Int. J. Radiat. Biol. pmid:11682008
Mishra SK et al. Dynamic chromatin remodeling on the HER2 promoter in human breast cancer cells. 2001 FEBS Lett. pmid:11682064
Sharma M and Sun Z 5'TG3' interacting factor interacts with Sin3A and represses AR-mediated transcription. 2001 Mol. Endocrinol. pmid:11682623
Lavoie R et al. Design and synthesis of a novel class of histone deacetylase inhibitors. 2001 Bioorg. Med. Chem. Lett. pmid:11597413
Bernhard D et al. Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts. 2001 Cell Death Differ. pmid:11598799
Hatama S et al. Isolation and sequencing of infectious clones of feline foamy virus and a human/feline foamy virus Env chimera. 2001 J. Gen. Virol. pmid:11714976
Yoshioka H et al. A novel in vitro system for analyzing parental allele-specific histone acetylation in genomic imprinting. 2001 J. Hum. Genet. pmid:11721881
He LZ et al. Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia. 2001 J. Clin. Invest. pmid:11696577
Rombouts K et al. Trichostatin A, lead compound for development of antifibrogenic drugs. 2001 Jul-Sep Acta Gastroenterol. Belg. pmid:11680040
McGuinness MC et al. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy. 2001 Sep-Oct Mol. Genet. Metab. pmid:11592822
Sanyal S et al. Differential regulation of the orphan nuclear receptor small heterodimer partner (SHP) gene promoter by orphan nuclear receptor ERR isoforms. 2002 J. Biol. Chem. pmid:11705994
Galasinski SC et al. Global regulation of post-translational modifications on core histones. 2002 J. Biol. Chem. pmid:11709551
Zhang W and Kone BC NF-kappaB inhibits transcription of the H(+)-K(+)-ATPase alpha(2)-subunit gene: role of histone deacetylases. 2002 Am. J. Physiol. Renal Physiol. pmid:12372765
Ailenberg M and Silverman M Trichostatin A-histone deacetylase inhibitor with clinical therapeutic potential-is also a selective and potent inhibitor of gelatinase A expression. 2002 Biochem. Biophys. Res. Commun. pmid:12379227
Yamashita K et al. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. 2002 Cancer Cell pmid:12498717
Fahrner JA et al. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. 2002 Cancer Res. pmid:12499261
Valapour M et al. Histone deacetylation inhibits IL4 gene expression in T cells. 2002 J. Allergy Clin. Immunol. pmid:11842291
McBurney MW et al. Evidence for repeat-induced gene silencing in cultured Mammalian cells: inactivation of tandem repeats of transfected genes. 2002 Exp. Cell Res. pmid:11855851
Hou M et al. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells. 2002 Exp. Cell Res. pmid:11855854
Remiszewski SW et al. Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates. 2002 J. Med. Chem. pmid:11831887
Avram D et al. COUP-TF (chicken ovalbumin upstream promoter transcription factor)-interacting protein 1 (CTIP1) is a sequence-specific DNA binding protein. 2002 Biochem. J. pmid:12196208
Guo Y et al. Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion. 2002 J. Biol. Chem. pmid:12198113
Wittich S et al. Structure-activity relationships on phenylalanine-containing inhibitors of histone deacetylase: in vitro enzyme inhibition, induction of differentiation, and inhibition of proliferation in Friend leukemic cells. 2002 J. Med. Chem. pmid:12109913
Toyooka S et al. Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures. 2002 Clin. Cancer Res. pmid:12114433
Choi HS et al. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex. 2002 Biochem. Biophys. Res. Commun. pmid:12200149
Toyooka S et al. Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells. 2002 Oncogene pmid:12082623
Maehara K et al. Effects of histone acetylation on transcriptional regulation of manganese superoxide dismutase gene. 2002 Biochem. Biophys. Res. Commun. pmid:12083788
Iezzi S et al. Stage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases. 2002 Proc. Natl. Acad. Sci. U.S.A. pmid:12032356
Nielsen J Combinatorial synthesis of natural products. 2002 Curr Opin Chem Biol pmid:12023109